After Robert W. Baird and Nomura gave Voyager Therapeutics Inc (NASDAQ: VYGR) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Debjit Chattopadhyay maintained a Buy rating on Voyager Therapeutics Inc today and set a price target of $22. The company’s shares closed on Friday at $16.50.
Chattopadhyay noted:
“Our $22 price target is based on a 13-year DCF analysis primarily focused on VY-AADC in PD, assuming Voyager opts to co-commercialize with 50/50 profit share and also includes probability adjusted development stage milestone payments Voyager Therapeutics, Inc. March 4, 2019 H.C. WAINWRIGHT & CO. EQUITY RESEARCH 3for the three programs covered under the Neurocrine collaboration agreement, as well as the recent Abbvie collaboration deal.”
According to TipRanks.com, Chattopadhyay is a 3-star analyst with an average return of 1.3% and a 47.9% success rate. Chattopadhyay covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Mersana Therapeutics Inc, and Autolus Therapeutics Plc.
Voyager Therapeutics Inc has an analyst consensus of Strong Buy, with a price target consensus of $22.57, representing a 36.8% upside. In a report issued on February 22, Robert W. Baird also reiterated a Buy rating on the stock with a $27 price target.
See today’s analyst top recommended stocks >>
Based on Voyager Therapeutics Inc’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $22.53 million. In comparison, last year the company had a GAAP net loss of $11.77 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
